Literature DB >> 21483637

Gastroesophageal reflux in cirrhotic patients without esophageal varices.

Jun Zhang1, Pei-Lin Cui, Dong Lv, Shi-Wei Yao, You-Qing Xu, Zhao-Xu Yang.   

Abstract

AIM: To evaluate the esophageal motility and abnormal acid and bile reflux incidence in cirrhotic patients without esophageal varices (EV).
METHODS: Seventy-eight patients with liver cirrhosis without EV confirmed by upper gastroesophageal endoscopy and 30 healthy control volunteers were prospectively enrolled in this study. All the patients were evaluated using a modified protocol including Child-Pugh score, upper gastrointestinal endoscopy, esophageal manometry, simultaneous ambulatory 24-h esophageal pH and bilirubin monitoring. All the patients and volunteers accepted the manometric study.
RESULTS: In the liver cirrhosis group, lower esophageal sphincter pressure (LESP, 15.32 ± 2.91 mmHg), peristaltic amplitude (PA, 61.41 ± 10.52 mmHg), peristaltic duration (PD, 5.32 ± 1.22 s), and peristaltic velocity (PV, 5.22 ± 1.11 cm/s) were all significantly abnormal in comparison with those in the control group (P < 0.05), and LESP was negatively correlated with Child-Pugh score. The incidence of reflux esophagitis (RE) and pathologic reflux was 37.18% and 55.13%, respectively (vs. control, P < 0.05). And the incidence of isolated abnormal acid reflux, bile reflux and mixed reflux was 12.82%, 14.10% and 28.21% in patients with liver cirrhosis without EV.
CONCLUSION: Cirrhotic patients without EV presented esophageal motor disorders and mixed acid and bile reflux was the main pattern; the cirrhosis itself was an important causative factor.

Entities:  

Keywords:  Bilirubin; Esophageal manometry; Esophageal varices; Gastroesophageal reflux disease; Liver cirrhosis; Monitoring; pH

Mesh:

Substances:

Year:  2011        PMID: 21483637      PMCID: PMC3072641          DOI: 10.3748/wjg.v17.i13.1753

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Tailored augmentation of the lower esophageal sphincter in experimental antireflux operations.

Authors:  S M Freys; K H Fuchs; J Heimbucher; A Thiede
Journal:  Surg Endosc       Date:  1997-12       Impact factor: 4.584

2.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

Review 3.  Clinical presentation, diagnosis, and management of gastroesophageal reflux disease.

Authors:  Mitchell S Cappell
Journal:  Med Clin North Am       Date:  2005-03       Impact factor: 5.456

4.  [Esophageal motor disorders in cirrhotic patients with esophageal varices non-submitted to endoscopic treatment].

Authors:  Priscila Pollo Flores; Eponina Maria de Oliveira Lemme; Henrique Sérgio Moraes Coelho
Journal:  Arq Gastroenterol       Date:  2006-01-19

Review 5.  Role of the gastric refluxate in gastroesophageal reflux disease: acid, weak acid and bile.

Authors:  Joel E Richter
Journal:  Am J Med Sci       Date:  2009-08       Impact factor: 2.378

6.  High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases.

Authors:  Bing Li; Bin Zhang; Jun Wei Ma; Peng Li; Lei Li; Yun Ming Song; Hui Guo Ding
Journal:  BMC Gastroenterol       Date:  2010-06-04       Impact factor: 3.067

7.  Frequency of gastroesophageal reflux in patients with liver cirrhosis.

Authors:  A M Ahmed; M A al Karawi; S Shariq; A E Mohamed
Journal:  Hepatogastroenterology       Date:  1993-10

8.  Role of duodenogastroesophageal reflux in the pathogenesis of esophageal mucosal injury and gastroesophageal reflux symptoms.

Authors:  Xiao-rong Xu; Zhao-shen Li; Duo-wu Zou; Guo-ming Xu; Ping Ye; Zhen-xing Sun; Qing Wang; Yan-jun Zeng
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

9.  Gastroesophageal reflux in cirrhotic patients with esophageal varices without endoscopic treatment.

Authors:  Rosana Bihari Schechter; Eponina Maria Oliveira Lemme; Henrique Sérgio Moraes Coelho
Journal:  Arq Gastroenterol       Date:  2007 Apr-Jun

Review 10.  Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

Authors:  Farida Millwala; Geoffrey C Nguyen; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

View more
  4 in total

1.  Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.

Authors:  C-H Chen; C-L Lin; C-H Kao
Journal:  Osteoporos Int       Date:  2016-02-10       Impact factor: 4.507

2.  Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial.

Authors:  Lívia Alves Amaral Santos; Talles Bazeia Lima; Hélio Rubens de Carvalho Nunes; Xingshun Qi; Fernando Gomes Romeiro
Journal:  Hepatol Int       Date:  2022-06-29       Impact factor: 6.047

Review 3.  Gastrointestinal Motility Disorders and Their Clinical Implications in Cirrhosis.

Authors:  Eleni Theocharidou; Ameet Dhar; David Patch
Journal:  Gastroenterol Res Pract       Date:  2017-05-11       Impact factor: 2.260

Review 4.  Spectrum of esophageal motility disorders in patients with liver cirrhosis.

Authors:  Mohamed Khalaf; Donald Castell; Puja Sukhwani Elias
Journal:  World J Hepatol       Date:  2020-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.